Drug details

Nesina (alogliptin tablets)

type of Antidiabetics, Dipeptyl Peptidase-IV Inhibitors

Nesina (alogliptin) is an anti-diabetic drug used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Nesina should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.

This drug may have the following side effects:

• headache.
• cold symptoms (stuffy nose, sore throat, sinus infection, sinus pain), or
  

The following drugs are related to Nesina, either as a replacement or used together:

• Precose (acarbose)
• Qternmet XR (dapagliflozin, saxagliptin, and metformin hydrochloride)
• Zegalogue (dasiglucagon injection)
• Trijardy XR (empagliflozin, linagliptin, and metformin hydrochloride extended-release tablets)
• Glucotrol (glipizide)
• Glucotrol XL (glipizide extended release)
• GlucaGen (glucagon [rdna origin]) for injection)
• Glucophage, Glucophage XR (metformin hcl)
• Glucovance (glyburide and metformin)
• Glumetza (metformin hcl)
• Glynase PresTab (micronized glyburide tablets)
• Glyset (miglitol)